Does MEROPENEM Cause Diffuse large b-cell lymphoma refractory? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Diffuse large b-cell lymphoma refractory have been filed in association with MEROPENEM (Meropenem). This represents 0.1% of all adverse event reports for MEROPENEM.
20
Reports of Diffuse large b-cell lymphoma refractory with MEROPENEM
0.1%
of all MEROPENEM reports
0
Deaths
20
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From MEROPENEM?
Of the 20 reports, 20 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which MEROPENEM Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL